Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01829828
Recruitment Status : Completed
First Posted : April 11, 2013
Last Update Posted : April 11, 2013
Sponsor:
Information provided by (Responsible Party):
Janssen Korea, Ltd., Korea

Brief Summary:
The purpose of this survey is to investigate the usefulness of a patient self-reported scoring tool on patient satisfaction improvement.

Condition or disease Intervention/treatment
Pain Behavioral: No intervention

Layout table for study information
Study Type : Observational
Actual Enrollment : 587 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: To Evaluate the Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management; Multicenter, Cross-sectional Study
Study Start Date : January 2012
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012


Group/Cohort Intervention/treatment
Inpatients with cancer pain
Inpatients admitted for cancer pain management
Behavioral: No intervention
This is an observational study with no investigational drug administered.




Primary Outcome Measures :
  1. Patient satisfaction with the control of cancer-related pain [ Time Frame: At baseline ]
    Patients will answer on a 7-point scale how satisfied they feel about their cancer pain treatment. The scale scores range from 1 (not at all satisfied) to 7 (very much satisfied).


Secondary Outcome Measures :
  1. Patient perception of pain [ Time Frame: At baseline ]
    Patients will answer on an 11-point scale how much pain they feel. The scales scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).

  2. Patient pain assessment by medical staff [ Time Frame: At baseline ]
    The patient's physician will mark on an 11-point scale the intensity of the patient pain. The scale scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Inpatients admitted for cancer pain management
Criteria

Inclusion Criteria:

  • Patients who have no experience with the study self-reported pain scoring tool
  • Patients who are able to understand and answer the pain scoring tool questions
  • Patients admitted to a hospital for more than 5 days due to cancer pain
  • Patients for whom their pain managing physicians completed the medical staff's survey

Exclusion Criteria:

  • Patients who cannot answer the questions due to cognitive impairments

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01829828


Sponsors and Collaborators
Janssen Korea, Ltd., Korea
Investigators
Layout table for investigator information
Study Director: Janssen Korea, Ltd., Korea Clinical Trial Janssen Korea, Ltd., Korea
Additional Information:
Layout table for additonal information
Responsible Party: Janssen Korea, Ltd., Korea
ClinicalTrials.gov Identifier: NCT01829828    
Other Study ID Numbers: CR100835
FENPAI4097 ( Other Identifier: Janssen Korea, Ltd., Korea )
FEN-KOR-9052 ( Other Identifier: Janssen Korea, Ltd., Korea )
First Posted: April 11, 2013    Key Record Dates
Last Update Posted: April 11, 2013
Last Verified: April 2013
Keywords provided by Janssen Korea, Ltd., Korea:
Pain
Cancer pain
Self-reported pain scoring tool
Opioid analgesics
Additional relevant MeSH terms:
Layout table for MeSH terms
Cancer Pain
Pain
Neurologic Manifestations
Signs and Symptoms